Tag: Interferon beta-1a

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Interferon beta-1a

DelveInsight Evaluates a Robust Multiple Sclerosis Clinical Trial as 100+ Influential Pharma ...

Added to Collection on: 2023-09-11 23:18:10

Tags for this article:

Multiple sclerosis
Interferon beta-1a
Biogen
Sanofi
Novartis
Management of multiple sclerosis
Cinnagen
Fingolimod
Antisense therapy
Bristol-Myers Squibb
Serono

Click the tags to see associated articles and topics

View Article Details
Ronald Blue Trust Inc. Sells 92 Shares of Biogen Inc. (NASDAQ:BIIB) - Defense World

Added to Collection on: 2023-10-01 16:04:38

Tags for this article:

Stock market
Spinal muscular atrophy
Biogen
Monoclonal antibodies
Equity securities
Aducanumab
Interferon beta-1a
Stock
Short
Penny stock
Ronald Blue Trust Inc.
Biogen Inc.

Click the tags to see associated articles and topics

View Article Details
Stratos Wealth Advisors LLC Decreases Stock Holdings in Biogen Inc. (NASDAQ:BIIB)

Added to Collection on: 2023-10-01 16:04:36

Tags for this article:

Spinal muscular atrophy
Biogen
Monoclonal antibodies
Equity securities
Aducanumab
Short
Stock
NASDAQ
Interferon beta-1a
Hedge fund
Stratos Wealth Advisors, LLC

Click the tags to see associated articles and topics

View Article Details
German Merck's MS drug falls short in pair of Phase 3 tests | BioPharma Dive

Added to Collection on: 2023-12-06 16:42:03

Tags for this article:

CAC 40
Sanofi
Merck Group
Teriflunomide
Bruton's tyrosine kinase
Interferon beta-1a
Merck KGaA

Click the tags to see associated articles and topics

View Article Details
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Fifth Third Bancorp - Defense World

Added to Collection on: 2024-01-21 17:42:06

Tags for this article:

Spinal muscular atrophy
Biogen
Interferon beta-1a
Aducanumab
Fifth Third Bancorp

Click the tags to see associated articles and topics

View Article Details
Biogen (BIIB) Q4 Earnings & Sales Miss Estimates, Stock Falls - Yahoo Finance

Added to Collection on: 2024-02-13 18:28:45

Tags for this article:

Pharmaceuticals policy
Spinal muscular atrophy
Biogen
Aducanumab
Interferon beta-1a
Dimethyl fumarate
Pharmaceutical industry in China
Reata Pharmaceuticals
Earnings surprise
Generic drug
United States
Tysabri
Tecfidera
Biogen Inc.

Click the tags to see associated articles and topics

View Article Details
Interferon Beta Drugs Market Advancements Highlighted by Sales Report 2023 - 2032

Added to Collection on: 2024-02-27 14:12:59

Tags for this article:

Cytokines
Interferon beta-1a
Interferon
Management of multiple sclerosis
Multiple sclerosis
Biogen
Peginterferon-alfa
Medication
Roche

Click the tags to see associated articles and topics

View Article Details
Undervalued by 28%, This Stock Is a Buy for Patient Investors - Morningstar

Added to Collection on: 2024-05-21 15:25:38

Tags for this article:

Orphan drugs
Spinal muscular atrophy
Specialty drugs
Biogen
Interferon beta-1a
Multiple sclerosis
Biosimilar
Dimethyl fumarate
Rituximab
Aducanumab
Natalizumab
Lecanemab
United States
Tysabri

Click the tags to see associated articles and topics

View Article Details
Mirae Asset Global Investments Co. Ltd. Sells 6396 Shares of Biogen Inc. (NASDAQ:BIIB)

Added to Collection on: 2024-07-07 19:49:30

Tags for this article:

Spinal muscular atrophy
Biogen
Aducanumab
Interferon beta-1a
Short

Click the tags to see associated articles and topics

View Article Details
Results From Outcomes-Based Agreement Analysis in Patients With Multiple Sclerosis

Added to Collection on: 2024-11-10 16:41:13

Tags for this article:

Cytokines
Multiple sclerosis
Interferon beta-1a
Dimethyl fumarate
Patient-reported outcome
Interferon
Expanded Disability Status Scale
Multiple sclerosis drug pipeline
Management of multiple sclerosis
Elizabeth C.S. Swart

Click the tags to see associated articles and topics

View Article Details